Zurn Elkay director discloses 17,844-share sale; retains 491,120 shares
Rhea-AI Filing Summary
Zurn Elkay Water Solutions director Timothy J. Jahnke reported a sale of 17,844 shares of ZWS common stock on 09/12/2025 under a Rule 10b5-1 trading plan at a weighted-average price of $47.55 per share (trades ranged $47.50–$47.60). After the sale he beneficially owns 311,120 shares directly and 180,000 shares indirectly through an irrevocable trust. The Form 4 was signed by Jeffrey J. LaValle under power of attorney for Mr. Jahnke. The filer offers to provide transaction-level share counts and prices upon request.
Positive
- Transaction executed under a Rule 10b5-1 plan, indicating prearranged trading instructions.
- Detailed disclosure of weighted-average price and offer to provide trade-level details on request.
- Substantial retained ownership: 311,120 shares direct plus 180,000 indirect via irrevocable trust.
Negative
- Reduction in direct holdings by 17,844 shares as a result of the reported sale.
- Form 4 shows an insider sale, which may be viewed negatively by some investors despite plan-based execution.
Insights
TL;DR: Director executed a prearranged sale under a 10b5-1 plan, modestly reducing direct holdings while retaining substantial ownership.
The sale of 17,844 shares at a weighted-average price of $47.55 was executed pursuant to a Rule 10b5-1 plan, which signals the trades were preplanned rather than opportunistic. Post-transaction direct beneficial ownership remains at 311,120 shares with an additional 180,000 held indirectly in an irrevocable trust, preserving significant insider alignment with shareholders. The issuer-level impact appears limited given the remaining insider stake, and full trade-level details are available on request as noted in the filing.
TL;DR: Proper disclosure and use of power of attorney; sale follows a documented 10b5-1 program.
The Form 4 discloses compliant procedures: a Rule 10b5-1 plan was used and the filing was executed under power of attorney, meeting standard governance and disclosure practices. The filing provides weighted-average sale pricing and offers to supply granular execution data, which improves transparency. There is no indication in the form of any other governance action or change in reporting status.